½ÃÀ庸°í¼­
»óǰÄÚµå
1685178

°æÀå ¿µ¾ç ÀåÄ¡ ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®(2025-2034³â)

Enteral Feeding Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °æÀå ¿µ¾ç ÀåÄ¡ ½ÃÀåÀº 2024³â¿¡´Â 65¾ï ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 5.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ½Å»ý¾Æ ¹× Á¶»ê¾Æ ¼öÀ¯¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °¡Á¤ °£È£ ȯ°æ¿¡¼­ °æÀå ¿µ¾ç ¼Ö·ç¼ÇÀÇ Ã¤Åà Ȯ´ë¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÚ¿¬ÀûÀ¸·Î À½½ÄÀ» ¼·ÃëÇÏ´Â µ¥ Àå¾Ö°¡ ÀÖ´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼­ °æÀå ¿µ¾ç ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿äµµ °è¼Ó Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °æÀå ¿µ¾ç °ø±ÞÀº ÀÇÇÐÀû ÁúȯÀ¸·Î ÀÎÇØ °æ±¸ ¼·Ãë°¡ ºÒ°¡´ÉÇÑ »ç¶÷µé¿¡°Ô Çʼö ¿µ¾ç¼Ò¸¦ Àü´ÞÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¾Ã°Å³ª »ïŰ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Ä¡·á¸¦ ¹Þ´Â ȯÀÚµéÀº ÀûÀýÇÑ ¿µ¾çÀ» À¯ÁöÇϱâ À§ÇØ ÀÌ·¯ÇÑ ÀåÄ¡¿¡ ÀÇÁ¸ÇÕ´Ï´Ù. °¡Á¤ ±â¹Ý Ä¡·á´Â ºñ¿ë È¿À²¼º°ú ÆíÀǼºÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ´Ü±â ¹× Àå±â ¿µ¾ç ¿ä±¸ »çÇ×À» ¸ðµÎ °ü¸®Çϱâ À§ÇØ °æÀå ¿µ¾ç °ø±Þ ¼Ö·ç¼ÇÀ» Á¡Á¡ ´õ ¸¹ÀÌ ±ÇÀåÇϰí ÀÖ½À´Ï´Ù.

Enteral Feeding Devices Market-IMG1

°æÀå ¿µ¾ç ÀåÄ¡ ½ÃÀåÀº °æÀå ¿µ¾ç °ø±Þ Æ©ºê, ÆßÇÁ, ÁÖ»ç±â, ¿µ¾ç °ø±Þ ¼¼Æ® ¹× ¾×¼¼¼­¸® µî Á¦Ç° À¯Çü¿¡ µû¶ó ºÐ·ùµË´Ï´Ù. °æÀå °ø±Þ Æ©ºê´Â 5.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü·Î 2034³â±îÁö 47¾ï ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ½ÃÀå È®´ë¸¦ ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Æ©ºê´Â ´Ù¾çÇÑ °Ç°­ »óŸ¦ °¡Áø °³Àο¡°Ô ¸ñÇ¥ ¿µ¾çÀ» Àü´ÞÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ±Þ¼º ¹× ¸¸¼º Ä¡·á ȯ°æ¿¡¼­ÀÇ ¿ªÇÒ·Î ÀÎÇØ ÀûÀýÇÑ ¿µ¾ç °ø±ÞÀ» º¸ÀåÇÏ´Â µ¥ ¼±È£µÇ´Â ¼Ö·ç¼ÇÀÔ´Ï´Ù. ´Ù¾çÇÑ À¯ÇüÀÇ ¿µ¾ç °ø±Þ Æ©ºê¸¦ »ç¿ëÇÒ ¼ö ÀÖÀ¸¹Ç·Î ÀÇ·á Àü¹®°¡´Â ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó ¸ÂÃãÇü Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. º´¿ø, Ŭ¸®´Ð, ȨÄÉ¾î ½Ã¼³¿¡¼­ ±¤¹üÀ§ÇÏ°Ô Ã¤Åõǰí ÀÖ´Â °æÀå ¿µ¾ç °ø±Þ Æ©ºê´Â ¿©ÀüÈ÷ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿øµ¿·ÂÀÔ´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 65¾ï ´Þ·¯
¿¹Ãø ±Ý¾× 116¾ï ´Þ·¯
CAGR 5.9%

ÀÌ ½ÃÀåÀº ¶ÇÇÑ ¼ºÀΰú ¼Ò¾Æ¿Í °°Àº ȯÀÚ ±×·ìÀ» ±â¹ÝÀ¸·Î ºÐ·ùµË´Ï´Ù. ¼ºÀÎ Ä«Å×°í¸®´Â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç 2025³âºÎÅÍ 2034³â±îÁö 5.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °æÀå ¿µ¾çÀ» ÇÊ¿ä·Î ÇÏ´Â ¼ºÀÎÀÇ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àå±â ÁúȯÀ» ¾Î°í ÀÖ´Â ¸¹Àº ¼ºÀεéÀº °Ç°­À» À¯ÁöÇϰí ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ Àå±â°£ °æÀå ¿µ¾ç °ø±ÞÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. ¿ÏÈ­ Ä¡·á¿¡¼­ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀüÅëÀûÀÎ ¼öÀ¯°¡ ºÒ°¡´ÉÇÑ °æ¿ì¿¡ ÇʼöÀûÀÎ ¿µ¾ç Áö¿øÀ» Á¦°øÇϱ⠶§¹®¿¡ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î, °æÀå ¿µ¾ç ÀåÄ¡´Â ¾Ï, ½Å°æ Àå¾Ö, À§Àå Áúȯ µî ´Ù¾çÇÑ ÀÇÇÐÀû Áúȯ¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¾Ï ºÎ¹®Àº 2024³â ½ÃÀå Á¡À¯À²ÀÇ 47.3%¸¦ Â÷ÁöÇß½À´Ï´Ù. ¸¹Àº Ä¡·á·Î ÀÎÇØ À½½Ä ¼·Ãë¿¡ ¾î·Á¿òÀ» °Þ±â ¶§¹®¿¡ ÀûÀýÇÑ ¿µ¾çÀ» À¯ÁöÇϱâ À§ÇØ °æÀå ¿µ¾ç °ø±ÞÀÌ ÇÊ¿äÇÕ´Ï´Ù. Àå±â Ä¡·á°¡ ÇÊ¿äÇÑ °³Àο¡°Ô ÀÌ·¯ÇÑ ÀåÄ¡´Â ¿¡³ÊÁö ¼öÁØÀ» ¾ÈÁ¤ÀûÀ¸·Î À¯ÁöÇϸ鼭 Ãß°¡ ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀº Ȩ Äɾî, º´¿ø ¹× ±âŸ ½Ã¼³ µî ÃÖÁ¾ »ç¿ëó¿¡ µû¶ó ³ª´¹´Ï´Ù. Ȩ ÄÉ¾î ºÎ¹®Àº 2024³â ½ÃÀåÀ» ÁÖµµÇßÀ¸¸ç 2034³â¿¡´Â 57¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àα¸ °í·ÉÈ­´Â °³ÀÎÀÌ µ¶¸³¼ºÀ» À¯ÁöÇϸ鼭 ÇÊ¿äÇÑ ¿µ¾ç Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖ´Â °¡Á¤ ±â¹Ý °æÀå ¿µ¾ç °ø±Þ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. Àå±â ÀÔ¿ø¿¡ ºñÇØ °¡Á¤ ±â¹Ý Ä¡·áÀÇ °æÁ¦¼ºÀº ¸¹Àº ȯÀÚ¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÔ´Ï´Ù. Á¢±Ù¼ºÀÌ ³ô¾ÆÁö¸é ƯÈ÷ º»ÀÎ ºÎ´ã ÀÇ·áºñ°¡ ³ôÀº Áö¿ª¿¡¼­ ´õ ¸¹Àº °³ÀÎÀÌ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù.

¹Ì±¹ °æÀå ¿µ¾ç ÀåÄ¡ ½ÃÀåÀº 2024³â 19¾ï ´Þ·¯ ±Ô¸ð·Î Æò°¡µÇ¾úÀ¸¸ç, 2034³â±îÁö 5.2%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í Ȩ ÇコÄÉ¾î ¼­ºñ½ºÀÇ Ã¤Åà Áõ°¡°¡ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¼±µµ ±â¾÷µéÀÇ ¿¬±¸ °³¹ß ³ë·ÂÀº Çõ½Å°ú Á¦Ç° °¡¿ë¼º¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿ìÈ£ÀûÀΠȯ±Þ Á¤Ã¥°ú ¿µ¾ç ¿ä¹ýÀ» Àå·ÁÇÏ´Â Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í °­È­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡
      • ½Å»ý¾Æ ¹× Á¶»ê¾Æ °æÀå ¿µ¾ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • °¡Á¤ °£È£ ȯ°æ¿¡¼­ °æÀå ¿µ¾ç¿¡ ´ëÇÑ ¼±È£µµ ±ÞÁõ
      • °æÀå ÀåÄ¡ÀÇ ±â¼ú ¹ßÀü
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • °æÀå ¿µ¾ç Æ©ºê¿Í °ü·ÃµÈ ÇÕº´Áõ
      • ¾ö°ÝÇÑ Á¤ºÎ ±ÔÁ¤ ¹× ±ÔÁ¤ Áؼö ¿ä±¸ »çÇ×
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼ú »óȲ
  • »óȯ ½Ã³ª¸®¿À
  • °¸ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç°º°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • °æÀå ¿µ¾ç Æ©ºê
    • ºñ°­ »ðÀÔ/ºñ°­ °æÀå ¿µ¾ç Æ©ºê
      • ºñÀ§°ü(Nasogastric tube)
      • ºñ°øÀå°ü (Nasojejunal tube)
    • º¹ºÎ »ðÀÔÇü/Àå·çÇü °æÀ念¾ç Æ©ºê
      • À§·ç°ü(Gastrostomy tube)
      • °øÀå·ç°ü / °øÀå »ðÀÔ Æ©ºê(Jejunostomy/jejunal tube)
      • À§°øÀå°ü (Gastrojejunal, GJ Æ©ºê) ¶Ç´Â °æ°øÀå°ü (Transjejunal tube)
  • °æÀå ¿µ¾ç ÆßÇÁ
  • °æÀå ¿µ¾ç ÁÖ»ç±â
  • °æÀå ¿µ¾ç °ø±Þ¼¼Æ®
  • ºÎ¼Óǰ/¾×¼¼¼­¸®

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ȯÀÚº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¼ºÀÎ
  • ¼Ò¾Æ

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ¾Ï
    • µÎ°æºÎ¾Ï
    • ¼ÒÈ­±â ¾Ï
    • ±âŸ ¾Ï
  • ÁßÃ߽Űæ°è(CNS) ¹× Á¤½Å °Ç°­
  • ºñ¾Ç¼º À§Àå(GI) Àå¾Ö
  • ±âŸ ¿ëµµ

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ÀçÅÃÄ¡·á
  • º´¿ø
  • ±âŸ ÃÖÁ¾ ¿ëµµ

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°(2021-2034³â)

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ALCOR SCIENTIFIC
  • Abbott
  • AMSINO
  • AMT
  • -Braun
  • Baxter
  • Becton Dickinson
  • Boston Scientific
  • Cardinal Health
  • CONMED
  • Cook Medical
  • DANONE
  • FRESENIUS KABI
  • HALYARD
  • MOOG
  • VYGON
HBR 25.04.17

The Global Enteral Feeding Devices Market was valued at USD 6.5 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2034. Growth in this sector is driven by the increasing prevalence of chronic illnesses, rising demand for neonatal and preterm feeding, and the expanding adoption of enteral feeding solutions in home care settings. As more individuals face conditions that impair their ability to consume food naturally, the demand for these devices continues to climb. Enteral feeding plays a crucial role in delivering essential nutrients to individuals who cannot eat orally due to medical conditions. Patients undergoing treatments that impact their ability to chew or swallow rely on these devices to maintain adequate nutrition. Home-based care is seeing significant growth due to its cost-effectiveness and convenience. Healthcare providers increasingly recommend enteral feeding solutions for managing both short-term and long-term nutritional needs.

Enteral Feeding Devices Market - IMG1

The enteral feeding devices market is categorized based on product type, including enteral feeding tubes, pumps, syringes, giving sets, and accessories. Enteral feeding tubes are expected to lead market expansion with a projected CAGR of 5.6%, reaching over USD 4.7 billion by 2034. These tubes are essential for delivering targeted nutrition to individuals dealing with various health conditions. Their role in acute and chronic care settings makes them a preferred solution for ensuring proper nourishment. The availability of different types of feeding tubes enables healthcare professionals to customize treatments based on individual patient needs. With broad adoption across hospitals, clinics, and home care facilities, enteral feeding tubes remain a primary driver of market growth.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$6.5 Billion
Forecast Value$11.6 Billion
CAGR5.9%

The market is also segmented based on patient groups, including adult and pediatric populations. The adult category holds the largest share and is expected to grow at a CAGR of 5.4% from 2025 to 2034. A rising number of adults requiring enteral nutrition contributes to sustained demand for these devices. Many adults with long-term conditions need enteral feeding for extended periods to maintain health and prevent complications. The increasing adoption of these solutions in palliative care further boosts demand, as they provide vital nutritional support in cases where traditional feeding is not an option.

In terms of application, enteral feeding devices are widely used across various medical conditions, including cancer, neurological disorders, and gastrointestinal diseases. The cancer segment accounted for 47.3% of the market share in 2024. Many treatments lead to difficulties in consuming food, making enteral feeding necessary to maintain adequate nutrition. For individuals requiring long-term care, these devices play an essential role in ensuring energy levels remain stable while preventing further complications.

The market is also divided by end-use, including home care, hospitals, and other facilities. The home care sector led the market in 2024 and is expected to reach USD 5.7 billion by 2034. An aging population drives demand for home-based enteral feeding, allowing individuals to receive necessary nutritional support while maintaining independence. The affordability of home-based care, compared to extended hospital stays, makes it a preferred choice for many patients. With increased accessibility, more individuals can benefit from these solutions, particularly in regions with high out-of-pocket healthcare expenses.

The U.S. enteral feeding devices market was valued at USD 1.9 billion in 2024 and is projected to grow at a CAGR of 5.2% through 2034. A growing elderly population and increasing adoption of home healthcare services support market expansion. Research and development efforts by leading companies contribute to innovation and product availability. Favorable reimbursement policies and government-backed initiatives promoting nutritional therapies further strengthen market growth.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of chronic diseases
      • 3.2.1.2 Increase in demand for neonatal and preterm enteral feeding
      • 3.2.1.3 Surging preference for enteral feeding at home care settings
      • 3.2.1.4 Technological advancements in enteral feeding devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Complications associated with enteral feeding tubes
      • 3.2.2.2 Stringent government regulations and compliance requirements
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Reimbursement scenario
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Enteral feeding tubes
    • 5.2.1 Nasoenteric/nasal feeding tube
      • 5.2.1.1 Nasogastric tube
      • 5.2.1.2 Nasojejunal tube
    • 5.2.2 Abdominal/ostotomy feeding tube
      • 5.2.2.1 Gastrostomy tube
      • 5.2.2.2 Jejunostomy/jejunal tube
      • 5.2.2.3 Gastrojejunal (GJ) or transjejunal tube
  • 5.3 Enteral feeding pumps
  • 5.4 Enteral syringes
  • 5.5 Giving sets
  • 5.6 Accessories

Chapter 6 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Adult
  • 6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cancer
    • 7.2.1 Head and neck cancer
    • 7.2.2 Gastrointestinal cancer
    • 7.2.3 Other cancer types
  • 7.3 Central nervous system (CNS) and mental health
  • 7.4 Non-malignant gastrointestinal (GI) disorders
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Home care
  • 8.3 Hospitals
  • 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 ALCOR SCIENTIFIC
  • 10.2 Abbott
  • 10.3 AMSINO
  • 10.4 AMT
  • 10.5 - Braun
  • 10.6 Baxter
  • 10.7 Becton Dickinson
  • 10.8 Boston Scientific
  • 10.9 Cardinal Health
  • 10.10 CONMED
  • 10.11 Cook Medical
  • 10.12 DANONE
  • 10.13 FRESENIUS KABI
  • 10.14 HALYARD
  • 10.15 MOOG
  • 10.16 VYGON
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦